Hyperglycemia suppresses cardiac stem cell homing to peri-infarcted myocardium via regulation of ERK1/2 and p38 MAPK activities

International Journal of Molecular Medicine

Volumn 30, Issue 6, 2012, Pages 1313-1320

  She, Tonghui ^a,b   Wang, Xiaoyan ^a   Gan, Yaping ^b   Kuang, Dong ^a   Yue, Junqiu ^a   Ni, Juan ^a   Zhao, Xia ^a   Wang, Guoping ^a  

^a HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b HUBEI UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

Author keywords

Cardiac stem cell; Homing; Hyperglycemia; Mitogen activated protein kinase; Stem cell factor

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; 4 (4 FLUOROPHENYL) 2 (4 METHYLSULFINYLPHENYL) 5 (4 PYRIDYL)IMIDAZOLE; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; STEM CELL FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL MIGRATION; CONTROLLED STUDY; CORONARY ARTERY LIGATION; DOWN REGULATION; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; HEART FUNCTION; HEART HEMODYNAMICS; HEART INFARCTION; HEART MUSCLE CELL; HYPERGLYCEMIA; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; IN VIVO STUDY; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; STEM CELL; WESTERN BLOTTING;

ANIMALS; CELL MOVEMENT; CELLS, CULTURED; DIABETES MELLITUS, EXPERIMENTAL; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FLAVONOIDS; GENE EXPRESSION; HYPERGLYCEMIA; IMIDAZOLES; MALE; MAP KINASE SIGNALING SYSTEM; MYOCARDIAL INFARCTION; MYOCARDIUM; MYOCYTES, CARDIAC; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHORYLATION; PROTEIN PROCESSING, POST-TRANSLATIONAL; PYRIDINES; RATS; RATS, SPRAGUE-DAWLEY; STEM CELL FACTOR; STEM CELLS; VENTRICULAR PRESSURE;

EID: 84869435584     PISSN: 11073756     EISSN: 1791244X     Source Type: Journal    
DOI: 10.3892/ijmm.2012.1125     Document Type: Article

References (37)

1. Rosamond W, Flegal K, Furie K, Go A, Greenlund K, Haase N, Hailpern SM, Ho M, Howard V, Kissela B, Kittner S, Lloyd- Jones D, McDermott M, Meigs J, Moy C, Nichol G, O'Donnell C, Roger V, Sorlie P, Steinberger J, Thom T, Wilson M and Hong Y: Heart disease and stroke statistics - 2008 update: a report from the American Heart Association Statistics Committee and Stroke Statistics Subcommittee. Circulation 117: e25-e146, 2008.
2. Evans SM, Mummery C and Doevendans PA: Progenitor cells for cardiac repair. Semin Cell Dev Biol 18: 153-160, 2007. (Pubitemid 46330848)
3. Kajstura J, Urbanek K, Rota M, Bearzi C, Hosoda T, Bolli R, Anversa P and Leri A: Cardiac stem cells and myocardial disease. J Mol Cell Cardiol 45: 505-513, 2008.
4. Lunde K and Aakhus S: Cell therapy in acute myocardial infarction: measures of efficacy. Heart 94: 969-970, 2008. (Pubitemid 352039874)
5. + embryonic-stem-cell-derived population. Nature 453: 524-528, 2008.
6. Beltrami AP, Barlucchi L, Torella D, Baker M, Limana F, Chimenti S, Kasahara H, Rota M, Musso E, Urbanek K, Leri A, Kajstura J, Nadal-Ginard B and Anversa P: Adult cardiac stem cells are multipotent and support myocardial regeneration. Cell 114: 763-776, 2003. (Pubitemid 37186770)
7. Fransioli J, Bailey B, Gude NA, Cottage CT, Muraski JA, Emmanuel G, Wu W, Alvarez R, Rubio M, Ottolenghi S, Schaefer E and Sussman MA: Evolution of the c-kit-positive cell response to pathological challenge in the myocardium. Stem Cells 26: 1315-1324, 2008.
8. Kuang D, Zhao X, Xiao GX, Ni J, Feng YM, Wu RL and Wang GP: Stem cell factor/c-kit signaling mediated cardiac stem cell migration via activation of p38 MAPK. Basic Res Cardiol 103: 265-273, 2008.
9. Heissig B, Hattori K, Dias S, Friedrich M, Ferris B, Hackett NR, Crystal RG, Besmer P, Lyden D, Moore MA, Werb Z and Rafii S: Recruitment of stem and progenitor cells from the bone marrow niche requires MMP-9 mediated release of kit-ligand. Cell 109: 625-637, 2002. (Pubitemid 34628725)
10. Vandervelde S, van Luyn MJ, Tio RA and Harmsen MC: Signaling factors in stem cell-mediated repair of infarcted myocardium. J Mol Cell Cardiol 39: 363-376, 2005. (Pubitemid 40995026)
11. Meloni M, Caporali A, Graiani G, Lagrasta C, Katare R, Van Linthout S, Spillmann F, Campesi I, Madeddu P, Quaini F and Emanueli C: Nerve growth factor promotes cardiac repair following myocardial infarction. Circ Res 106: 1275-1284, 2010.
12. Xiang FL, Lu X, Hammoud L, Zhu P, Chidiac P, Robbins J and Feng QP: Cardiomyocyte-specific overexpression of human stem cell factor improves cardiac function and survival after myocardial infarction in mice. Circulation 120: 1065-1074, 2009.
13. Da Silva CA, Heilbock C, Kassel O and Frossard N: Transcription of stem cell factor (SCF) is potentiated by glucocorticoids and interleukin-1beta through concerted regulation of a GRE-like and an NF-kappaB response element. FASEB J 17: 2334-2336, 2003. (Pubitemid 39561484)
14. Bartnik M, Rydén L, Ferrari R, Malmberg K, Pyörälä K, Simoons M, Standl E, Soler-Soler J and Ohrvik J; Euro Heart Survey Investigators: The prevalence of abnormal glucose regulation in patients with coronary artery disease across Europe. The Euro Heart Survey on diabetes and the heart. Eur Heart J 25: 1880-1890, 2004. (Pubitemid 39452604)
15. Goyal A, Mahaffey KW, Garg J, Nicolau JC, Hochman JS, Weaver WD, Theroux P, Oliveira GB, Todaro TG, Mojcik CF, Armstrong PW and Granger CB: Prognostic significance of the change in glucose level in the first 24 h after acute myocardial infarction: results from the CARDINAL study. Eur Heart J 27: 1289-1297, 2006. (Pubitemid 43998101)
16. Kosiborod M, Rathore SS, Inzucchi SE, Masoudi FA, Wang Y, Havranek EP and Krumholz HM: Admission glucose and mortality in elderly patients hospitalized with acute myocardial infarction: implications for patients with and without recognized diabetes. Circulation 111: 3078-3086, 2005. (Pubitemid 40847785)
17. Deedwania P, Kosiborod M, Barrett E, Ceriello A, Isley W, Mazzone T and Raskin P: Hyperglycemia and acute coronary syndrome: a scientific statement from the American Heart Association Diabetes Committee of the Council on Nutrition, Physical Activity, and Metabolism. Circulation 117: 1610-1619, 2008. (Pubitemid 351440650)
18. Opie LH: Metabolic management of acute myocardial infarction comes to the fore and extends beyond control of hyperglycemia. Circulation 117: 2172-2177, 2008.
19. Carroll R and Yellon DM: Delayed cardioprotection in a human cardiomyocyte-derived cell line: the role of adenosine, p38MAP kinase and mitochondrial KATP. Basic Res Cardiol 95: 243-249, 2000. (Pubitemid 30325900)
20. Fryer RM, Hsu AK and Gross GJ: ERK and p38 MAP kinase activation are components of opioid-induced delayed cardioprotection. Basic Res Cardiol 96: 136-142, 2001. (Pubitemid 32236782)
21. Yue TL, Wang C, Romanic AM, Kikly K, Keller P, DeWolf WE Jr., Hart TK, Thomas HC, Storer B, Gu JL, Wang X and Feuerstein GZ: Staurosporine-induced apoptosis in cardiomyocytes: A potential role of caspase-3. J Mol Cell Cardiol 30: 495-507, 1998. (Pubitemid 28132729)
22. Barbash IM, Chouraqui P, Baron J, Feinberg MS, Etzion S, Tessone A, Miller L, Guetta E, Zipori D, Kedes LH, Kloner RA and Leor J: Systemic delivery of bone marrow-derived mesenchymal stem cells to the infarcted myocardium: feasibility, cell migration, and body distribution. Circulation 108: 863-868, 2003. (Pubitemid 37022130)
23. Song ZH and Zhong M: CB1 cannabinoid receptor-mediated cell migration. J Pharmacol Exp Ther 294: 204-209, 2000. (Pubitemid 30434688)
24. Hierlihy AM, Seale P, Lobe CG, Rudnicki MA and Megeney LA: The post-natal heart contains a myocardial stem cell population. FEBS Lett 530: 239-243, 2002. (Pubitemid 35248218)
25. Laugwitz KL, Moretti A, Lam J, Gruber P, Chen Y, Woodard S, Lin LZ, Cai CL, Lu MM, Reth M, Platoshyn O, Yuan JX, Evans S and Chien KR: Postnatal isl1+ cardioblasts enter fully differentiated cardiomyocyte lineages. Nature 433: 647-653, 2005. (Pubitemid 40282999)
26. Fazel S, Chen L, Weisel RD, Angoulvant D, Seneviratne C, Fazel A, Cheung P, Lam J, Fedak PW, Yau TM and Li RK: Cell transplantation preserves cardiac function after infarction by infarct stabilization: augmentation by stem cell factor. J Thorac Cardiovasc Surg 130: 1310, 2005.
27. Lutz M, Rosenberg M, Kiessling F, Eckstein V, Heger T, Krebs J, Ho AD, Katus HA and Frey N: Local injection of stem cell factor (SCF) improves myocardial homing of systemically delivered c-kit+ bone marrow-derived stem cells. Cardiovasc Res 77: 143-150, 2008. (Pubitemid 351195155)
28. Nishida E and Gotoh Y: The MAP kinase cascade is essential for diverse signal transduction pathways. Trends Biochem Sci 18: 128-131, 1993. (Pubitemid 23105313)
29. Sanchez I, Hughes RT, Mayer BJ, Yee K, Woodgett JR, Avruch J, Kyriakis JM and Zon LI: Role of SAPK/ERK kinase-1 in the stress-activated pathway regulating transcription factor c-Jun. Nature 372: 794-798, 1994.
30. Reber L, Vermeulen L, Haegeman G and Frossard N: Ser276 phosphorylation of NF-kB p65 by MSK1 controls SCF expression in inflammation. PLoS One 4: e4393, 2009.
31. Ren J, Zhang S, Kovacs A, Wang Y and Muslin AJ: Role of p38alpha MAPK in cardiac apoptosis and remodeling after myocardial infarction. J Mol Cell Cardiol 38: 617-623, 2005. (Pubitemid 40461825)
32. Yoshida K, Yoshiyama M, Omura T, Nakamura Y, Kim S, Takeuchi K, Iwao H and Yoshikawa J: Activation of mitogen-activated protein kinases in the non-ischemic myocardium of an acute myocardial infarction in rats. Jpn Circ J 65: 808-814, 2001.
33. Frantz S, Behr T, Hu K, Fraccarollo D, Strotmann J, Goldberg E, Ertl G, Angermann CE and Bauersachs J: Role of p38 mitogen-activated protein kinase in cardiac remodelling. Br J Pharmacol 150: 130-135, 2007. (Pubitemid 46160602)
34. Matsumoto-Ida M, Takimoto Y, Aoyama T, Akao M, Takeda T and Kita T: Activation of TGF-beta1-TAK1-p38 MAPK pathway in spared cardiomyocytes is involved in left ventricular remodeling after myocardial infarction in rats. Am J Physiol Heart Circ Physiol 290: H709-H715, 2006.
35. Hue J, Kim A, Song H, Choi I, Park H, Kim T, Lee WJ, Kang H and Cho D: IL-18 enhances SCF production of melanoma cells by regulating ROI and p38 MAPK activity. Immunol Lett 96: 211-217, 2005. (Pubitemid 39600777)
36. Takata H, Ikeda Y, Suehiro T, Ishibashi A, Inoue M, Kumon Y and Terada Y: High glucose induces transactivation of the alpha2-HS glycoprotein gene through the ERK1/2 signaling pathway. J Atheroscler Thromb 16: 448-456, 2009.
37. Ku PM, Chen LJ, Liang JR, Cheng KC, Li YX and Cheng JT: Molecular role of GATA binding protein 4 (GATA-4) in hyperglycemia-induced reduction of cardiac contractility. Cardiovasc Diabetol 10: 57, 2011.